Adrenal gland

Aorta, media

Appendix, mucosa – In the entire GIT system, few scattered TACSTD2 positive epithelial cells can always occur.

Appendix, mucosa

Appendix, muscular wall

Bone marrow – A small subset of positive cells is seen in the bone marrow, perhaps reflecting granulocytes and their precursor cells.

Breast – A strong TACSTD2 immunostaining is seen in all epithelial cells of breast glands.

Bronchus, mucosa – A strong TACSTD2 positivity is seen in all cells of the respiratory epithelium.

Cerebellum (molecular layer, Purkinje cell layer, granule cell layer, white matter)

Cerebellum (molecular layer, Purkinje cell layer, granule cell layer)

Cerebrum, grey matter

Cerebrum, white matter

Cerebrum, white matter

Colon descendens, muscular wall

Duodenum, Brunner gland

Duodenum, mucosa

Epididymis – TACSTD2 staining is most prominent in basal cells, but tall columnar cells also show a variable staining.

Esophagus, squamous epithelium – A strong, predominantly membranous TACSTD2 positivity occurs in the squamous epithelium but the basal cell layers are either negative or markedly less stained than the more superficial cell layers.

Fallopian tube, mucosa

Fat

Gallbladder, epithelium – A strong TACSTD2 staining is seen in all epithelial cells of the gallbladder epithelium.

Heart muscle

Ileum, mucosa – In the entire GIT system, few scattered TACSTD2 positive epithelial cells can always occur.

Ileum, mucosa

Kidney, cortex – A strong TACSTD2 immunostaining occurs in distal tubuli and collecting ducts while staining is weak to moderate in the parietal layer of the Bowman capsule.

Kidney, medulla – Strong TACSTD2 immunostaining in collecting ducts.

Liver – A strong TACSTD2 staining is seen in intrahepatic bile ducts.

Lung – A moderate TACSTD2 staining occurs in all pneumocytes of the lung.

Lymph node

Ovary, stroma

Pancreas – A strong positivity is seen in excretory and intercalated ducts while acinar cells show a variable staining intensity predominantly occurring at the apical membranes. Staining is largely absent in an islet of Langerhans.

Pancreas – A strong positivity is seen in excretory and intercalated ducts while acinar cells show a variable staining intensity predominantly occurring at the apical membranes.

Parathyroid gland

Parotid gland

Pituitary gland, anterior lobe – A small subset of epithelial cells of the adenohypophysis show a moderate TACSTD2 positivity.

Pituitary gland, posterior lobe

Placenta (amnion) – Strong TACSTD2 staining of amnion cells.

Placenta (chorion) – Moderate to strong TACSTD2 staining in chorion cells.

Placenta, early – TACSTD2 staining is strong in the cytotrophoblast of the placenta.

Placenta, mature – TACSTD2 staining is strongest in the cytotrophoblast of the placenta. An additional superficial membranous staining occurs in the syncytiotrophoblast of the mature placenta.

Prostate

Rectum, mucosa – In the entire GIT system, few scattered TACSTD2 positive epithelial cells can always occur.

Seminal vesicle

Sinus paranasales – A strong TACSTD2 positivity is seen in all cells of the respiratory epithelium.

Skeletal muscle

Skin – A strong, predominantly membranous TACSTD2 immunostaining is seen the squamous epithelium of the in skin but the basal cell layers are either negative or markedly less stained than the more superficial cell layers.

Spleen

Stomach, antrum – The superficial epithelial cell layers of the stomach can stain TACSTD2 positive.

Stomach, antrum – TACSTD2 positivity is not always seen in stomach samples

Stomach, corpus

Testis

Thymus – In the thymus, cells of corpuscles of Hassall’s show strong TACSTD2 staining while staining is weaker in other thymic epithelial cells.

Thyroid gland – A moderate to strong TACSTD2 staining occurs at the apical membranes of cells in a variable number of follicles.

Tonsil – In the tonsil, a strong TACSTD2 staining is seen in squamous epithelium of the crypts. In addition, a faint TACSTD2 staining occurs in a fraction of germinal centre cells.

Tonsil, surface epithelium – A strong, predominantly membranous TACSTD2 staining occurs in the squamous epithelium of tonsil surface where all cell layers are equally stained.

Urinary bladder, muscular wall

Urinary bladder, urothelium – A strong, predominantly membranous TACSTD2 staining occurs in the urothelium. All cell layers are equally stained.

Uterus, ectocervix – A strong, predominantly membranous TACSTD2 positivity is seen in the squamous epithelium of uterine cervix. All cell layers are equally stained

Uterus, endocervix – A strong TACSTD2 immunostaining is seen in all epithelial cells of the endocervix.

Uterus, endometrium (pregnancy) – Strong TACSTD2 immunostaining of endometrial glands while decidua cells are TACSTD2 negative.

Uterus, endometrium (proliferation) – Strong TACSTD2 immunostaining in endometrial glands.

Uterus, endometrium (secretion) – TACSTD2 immunostaining is variable in the endometrium and does not always involve all glands.

Uterus, myometrium